Holen Sie sich die Stockscreener-App
0.70
0.01%
-0.000100
Handel nachbörslich:
.69
-0.01
-1.43%
Finanzdaten der Xilio Therapeutics Inc-Aktie (XLO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
175.90%
8.084
|
2.93 | 1.724 | 2.263 | 2.357 |
Operating Expenses
|
33.78%
22.45
|
16.78 | 15.35 | 17.02 | 17.06 |
| Benefits Costs and Expenses |
100.00%
-
|
16.20 | 14.82 | - | - |
| Costs And Expenses |
38.62%
22.45
|
16.20 | 14.82 | 17.02 | 17.06 |
| Operating Income/Loss |
3.72%
-14.37
|
-13.85 | -13.63 | -14.76 | -14.70 |
| Nonoperating Income/Loss |
352.22%
-1.478
|
0.586 | 0.536 | 0.742 | 0.779 |
| Income/Loss From Continuing Operations Before Tax |
160.94%
8.084
|
-13.27 | -13.09 | 2.263 | 2.357 |
| Income/Loss From Continuing Operations After Tax |
19.44%
-15.84
|
-13.27 | -13.09 | -14.02 | -13.93 |
|
Net Income/Loss
|
19.44%
-15.84
|
-13.27 | -13.09 | -14.02 | -13.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
29.11%
96.45
|
74.70 | 3.7486 | 63.47 | 57.76 |
| Basic Earnings Per Share |
11.11%
-0.16
|
-0.18 | -0.18 | -0.22 | -0.24 |
| Diluted Earnings Per Share |
11.11%
-0.16
|
-0.18 | -0.18 | -0.22 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):